Abelcet and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abelcet (amphotericin b) and Meropenem (meropenem). Common drug interactions include bradycardia among females and hyperbilirubinaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Abelcet and Meropenem. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Abelcet?

Abelcet has active ingredients of amphotericin b. eHealthMe is studying from 853 Abelcet users. Check the latest studies of Abelcet.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

67 people who take Abelcet and Meropenem together, and have interactions are studied.

Abelcet and Meropenem drug interactions.

What are the common drug interactions of Abelcet and Meropenem, by gender? *:

female:

Bradycardia (abnormally slow heart action)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Conjunctival haemorrhage (bleeding underneath the conjunctiva)
Cough
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Diarrhoea
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dyspnoea (difficult or laboured respiration)
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Eye movement disorder

male:

Hyperbilirubinaemia (excess of bilirubin in the blood)
Neutropenia (an abnormally low number of neutrophils)
Respiratory rate increased (excess breathing rate/min)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Acute myocardial infarction (acute heart attack)
Acute pulmonary oedema (sudden deposit of fluid in the lung))
Body temperature increased
Hypokalaemia (low potassium)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Abelcet and Meropenem, by age (0-1 to 60+)? *:

0-1:

Haemorrhagic diathesis (bleeding tendency)
Thrombocytopenia (decrease of platelets in blood)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Arrhythmia (irregular heartbeat)
Cardiac failure
Dyspnoea (difficult or laboured respiration)
Gamma-glutamyltransferase increased
Haemorrhage intracranial (bleeding within the skull)
Hepatic failure (liver failure)

2-9:

Abdominal pain
Cytomegalovirus infection
Fatigue (feeling of tiredness)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Hypotension (abnormally low blood pressure)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Somnolence (a state of near-sleep, a strong desire for sleep)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Vasculitis (inflammation of a blood vessel or blood vessels)

10-19:

Chills (felling of cold)
Pyrexia (fever)
Peripheral coldness
Aplasia (defective development or congenital absence of an organ or tissue)
Blood culture positive
Blood pressure decreased
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Heart rate increased
Hypotension (abnormally low blood pressure)
Oxygen saturation decreased

20-29:

Diarrhoea
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Fatigue (feeling of tiredness)
Headache (pain in head)
Hepatomegaly (abnormal enlargement of the liver)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Hypertension (high blood pressure)
Incoherent (talking in a confused and unclear way)
Lung disorder (lung disease)
Mucosal inflammation (infection of mucous membrane)

30-39:

Pulmonary embolism (blockage of the main artery of the lung)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Blood pressure increased
Cardiac arrest
Colitis (inflammation of colon)
Hypotension (abnormally low blood pressure)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Oxygen saturation decreased
Respiratory rate increased (excess breathing rate/min)

40-49:

Body temperature increased
Chills (felling of cold)
Heart rate increased
Hypertension (high blood pressure)
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Rash
Acidosis (build-up of carbon dioxide in the blood)
Cardiac arrest
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Fungaemia (fungi circulate in the blood)

50-59:

Septic shock (shock due to blood infection)
Drug ineffective
Pneumonia fungal
Geotrichum infection (fungal infection by geotrichum)
Drug resistance (reduction in effectiveness of a drug)
Pathogen resistance
Deafness
Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
Pain
Respiratory failure (inadequate gas exchange by the respiratory system)

60+:

Thrombocytopenia (decrease of platelets in blood)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Hyperhidrosis (abnormally increased sweating)
Hypertension (high blood pressure)
Hypokalaemia (low potassium)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Respiratory rate increased (excess breathing rate/min)
Restlessness (not able to rest)
Blood pressure systolic decreased
Body temperature increased

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 21 people, 31.34%
Fungal Infection: 10 people, 14.93%
Geotrichum Infection (fungal infection by geotrichum): 7 people, 10.45%
Constipation: 6 people, 8.96%
Fever: 6 people, 8.96%
Vaginal Bleeding: 6 people, 8.96%
Sepsis (a severe blood infection that can lead to organ failure and death): 6 people, 8.96%
Pain: 5 people, 7.46%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 7.46%
Abdominal Pain: 5 people, 7.46%

* Approximation only. Some reports may have incomplete information.

Do you take Abelcet and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously